Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,174,637
+$2,640,986 QoQ
Shares Held
100,290
+13.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#107
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. ARWR ranks #11 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,174,637 | 100,290 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,533,651 | 88,256 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,940,810 | 74,421 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,793,686 | 52,006 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $721,459 | 45,662 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $337,202 | 26,468 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,045,825 | 55,629 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $492,171 | 25,409 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $734,891 | 28,276 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $739,480 | 25,856 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $563,070 | 18,401 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $460,497 | 17,138 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $644,981 | 18,087 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $365,125 | 14,375 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $622,758 | 15,354 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $482,298 | 14,593 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $487,412 | 13,843 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $581,129 | 12,636 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $833,921 | 12,578 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $831,754 | 13,323 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,041,295 | 12,573 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $616,749 | 9,301 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $665,172 | 8,669 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $359,680 | 8,353 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $360,766 | 8,353 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $307,004 | 10,671 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||